Associations between apolipoprotein E phenotype, glucose metabolism and cognitive function in men. An explorative study in a population sample

Diabetic Medicine

Volumn 18, Issue 12, 2001, Pages 991-997

  Helkala, E L ^a   Lakka, T ^a   Vanhanen, M ^b   Tuomainen, T P ^a   Ehnholm, C ^c   Kaplan, G A ^d   Salonen, J T ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

A polipoprotein E phenotype; Cognitive functions; Glucose metabolism

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ADULT; AGE DISTRIBUTION; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; POPULATION RESEARCH;

EID: 0035676137     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0742-3071.2001.00588.x     Document Type: Article

References (44)

1. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
2. Association of apolipoprotein E phenotypes with late onset alzheimer's disease: Population based study
3. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele
4. Episodic memory changes are associated with the ApoE-ε4 allele in nondemented older adults
5. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women
6. Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein e4 phenotype in centenarians
7. The association of apolipoprotein E polymorphism with cognitive performance: Population based study
8. Memory functions in human subjects with different apolioprotein E phenotypes during a 3-year population-based follow-up study
9. The mental efficiency of the elderly person with type II diabetes mellitus
10. Cognitive and affective disorders in elderly diabetics
11. Short-term and long-term memory in elderly patients with NIDDM
12. Is type II diabetes associated with an increased risk of cognitive dysfunction?
13. Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men
14. Atherosclerosis, apolipoprotein-E and the prevalence of dementia and Alzheimer's disease in the Rotterdam study
15. Is there a continuing need for longitudinal epidemiological research? The Kuopio Ischaemic heart disease risk factor study
16. Diabetes Mellitus
17. Apolipoprotein E Polymorphism in the Finnish population: Gene frequencies and relation to lipoprotein concentration
18. Evaluating storage, retention, and retrieval in disordered memory and learning
19. Validity of the Trail Making test as an indicator of organic brain damage
20. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein e4 phenotype: Cross sectional population based study
21. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: Relationship to severity of dementia and apolipoprotein E phenotype
22. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study
23. The association of non-insulin-dependent diabetes mellitus and cognitive function in an older cohort
24. Cognitive function in an elderly population with persistent impaired glucose tolerance
25. Glucose intolerance, hyperinsulinemia and cognitive function in a general population of elderly men
26. Risk of dementia among persons with diabetes mellitus: A population-based cohort study
27. Diabetes mellitus and risk of dementia in a elderly population. The Rotterdam Study
28. Decreased cognitive function in aging non-insulin-dependent diabetic patients
29. Cognitive function and metabolic state in elderly diabetic patients
30. Effect of type II diabetes mellitus on cognitive function
31. Type II diabetes and cognitive function
32. Decreased brain function in patients with non-insulin-dependent diabetes mellitus
33. Alterations in glucose metabolism in patients with Alzheimer's disease
34. Relationship between hyperglycemia and cognitive function in older NIDDM patients
35. Cortical function in elderly non-insulin dependent diabetic patients. Behavioral and electrophysiologic studies
36. Psychometric evaluation of performance in diabetes mellitus
37. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases
38. Glucose regulation and cognitive functions: Relation to Alzheimer's disease and diabetes
39. Is diabetes associated with cognitive impairment and cognitive decline among older women?
40. Diabetes and cognitive impairment: A community-based study of elderly subjects
41. Insulin and cognitive function in an elderly population
42. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E phenotype
43. Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study
44. Relationship between apolipoprotein E polymorphism, postprandial hyperlipemia and hemostatic variables in patients with combined hyperlipemia